No association between the very low density lipoprotein receptor gene and late-onset Alzheimer's disease nor interaction with the apolipoprotein E gene in population-based and clinic samples

Daniele Daniele Fallin, Ann C. Gauntlett, Paul Scibelli, Xingang Cai, Ranjan Duara, Michael Gold, Fiona Crawford, Michael Mullan

Research output: Contribution to journalArticle

Abstract

It is now commonly known that possession of one of the three common alleles of the apolipoprotein E (APOE) gene (allele ε4) confers an increased risk for both familial and sporadic Alzheimer's disease (AD), and that this risk is dose-dependent. Other genes that may play a role in AD, either through independent association with the disease or through modification of the existing APOE risk, are under investigation. One such gene, the very low density lipoprotein receptor (VLDL-R) gene, was reported by Okuizumi et al. to be independently associated with AD in a Japanese population, but not interactive with the APOE4 conferred risk. Their clinic-based data set demonstrated a 2-fold increased risk conferred by the 5-repeat allele of a polymorphism in VLDL-R. As recruitment from a clinic rather than a population-based sample may result in a distortion of allele frequencies, as has been shown with APOE allele frequencies, it is important to investigate this association in a population-based study. We have genotyped both population and clinic-based AD data sets at this VLDL-R polymorphism, and we find no independent association between the VLDL-R gene and the occur rence of AD in either sample. Further, despite the biochemical relationship between the VLDL-R and APOE proteins, we find no significant statistical interaction between the alleles at these loci.

Original languageEnglish (US)
Pages (from-to)299-305
Number of pages7
JournalGenetic Epidemiology
Volume14
Issue number3
DOIs
StatePublished - 1997
Externally publishedYes

Fingerprint

Apolipoproteins E
Alzheimer Disease
Alleles
Population
Genes
Gene Frequency
VLDL receptor
Proteins
Datasets

Keywords

  • Alzheimer's disease risk
  • Genetic interaction
  • Very low density lipoprotein receptor gene

ASJC Scopus subject areas

  • Genetics(clinical)
  • Epidemiology

Cite this

No association between the very low density lipoprotein receptor gene and late-onset Alzheimer's disease nor interaction with the apolipoprotein E gene in population-based and clinic samples. / Fallin, Daniele Daniele; Gauntlett, Ann C.; Scibelli, Paul; Cai, Xingang; Duara, Ranjan; Gold, Michael; Crawford, Fiona; Mullan, Michael.

In: Genetic Epidemiology, Vol. 14, No. 3, 1997, p. 299-305.

Research output: Contribution to journalArticle

Fallin, Daniele Daniele ; Gauntlett, Ann C. ; Scibelli, Paul ; Cai, Xingang ; Duara, Ranjan ; Gold, Michael ; Crawford, Fiona ; Mullan, Michael. / No association between the very low density lipoprotein receptor gene and late-onset Alzheimer's disease nor interaction with the apolipoprotein E gene in population-based and clinic samples. In: Genetic Epidemiology. 1997 ; Vol. 14, No. 3. pp. 299-305.
@article{9b9231d129a74dcfbe1ddb8356cbf36a,
title = "No association between the very low density lipoprotein receptor gene and late-onset Alzheimer's disease nor interaction with the apolipoprotein E gene in population-based and clinic samples",
abstract = "It is now commonly known that possession of one of the three common alleles of the apolipoprotein E (APOE) gene (allele ε4) confers an increased risk for both familial and sporadic Alzheimer's disease (AD), and that this risk is dose-dependent. Other genes that may play a role in AD, either through independent association with the disease or through modification of the existing APOE risk, are under investigation. One such gene, the very low density lipoprotein receptor (VLDL-R) gene, was reported by Okuizumi et al. to be independently associated with AD in a Japanese population, but not interactive with the APOE4 conferred risk. Their clinic-based data set demonstrated a 2-fold increased risk conferred by the 5-repeat allele of a polymorphism in VLDL-R. As recruitment from a clinic rather than a population-based sample may result in a distortion of allele frequencies, as has been shown with APOE allele frequencies, it is important to investigate this association in a population-based study. We have genotyped both population and clinic-based AD data sets at this VLDL-R polymorphism, and we find no independent association between the VLDL-R gene and the occur rence of AD in either sample. Further, despite the biochemical relationship between the VLDL-R and APOE proteins, we find no significant statistical interaction between the alleles at these loci.",
keywords = "Alzheimer's disease risk, Genetic interaction, Very low density lipoprotein receptor gene",
author = "Fallin, {Daniele Daniele} and Gauntlett, {Ann C.} and Paul Scibelli and Xingang Cai and Ranjan Duara and Michael Gold and Fiona Crawford and Michael Mullan",
year = "1997",
doi = "10.1002/(SICI)1098-2272(1997)14:3<299::AID-GEPI7>3.0.CO;2-0",
language = "English (US)",
volume = "14",
pages = "299--305",
journal = "Genetic Epidemiology",
issn = "0741-0395",
publisher = "Wiley-Liss Inc.",
number = "3",

}

TY - JOUR

T1 - No association between the very low density lipoprotein receptor gene and late-onset Alzheimer's disease nor interaction with the apolipoprotein E gene in population-based and clinic samples

AU - Fallin, Daniele Daniele

AU - Gauntlett, Ann C.

AU - Scibelli, Paul

AU - Cai, Xingang

AU - Duara, Ranjan

AU - Gold, Michael

AU - Crawford, Fiona

AU - Mullan, Michael

PY - 1997

Y1 - 1997

N2 - It is now commonly known that possession of one of the three common alleles of the apolipoprotein E (APOE) gene (allele ε4) confers an increased risk for both familial and sporadic Alzheimer's disease (AD), and that this risk is dose-dependent. Other genes that may play a role in AD, either through independent association with the disease or through modification of the existing APOE risk, are under investigation. One such gene, the very low density lipoprotein receptor (VLDL-R) gene, was reported by Okuizumi et al. to be independently associated with AD in a Japanese population, but not interactive with the APOE4 conferred risk. Their clinic-based data set demonstrated a 2-fold increased risk conferred by the 5-repeat allele of a polymorphism in VLDL-R. As recruitment from a clinic rather than a population-based sample may result in a distortion of allele frequencies, as has been shown with APOE allele frequencies, it is important to investigate this association in a population-based study. We have genotyped both population and clinic-based AD data sets at this VLDL-R polymorphism, and we find no independent association between the VLDL-R gene and the occur rence of AD in either sample. Further, despite the biochemical relationship between the VLDL-R and APOE proteins, we find no significant statistical interaction between the alleles at these loci.

AB - It is now commonly known that possession of one of the three common alleles of the apolipoprotein E (APOE) gene (allele ε4) confers an increased risk for both familial and sporadic Alzheimer's disease (AD), and that this risk is dose-dependent. Other genes that may play a role in AD, either through independent association with the disease or through modification of the existing APOE risk, are under investigation. One such gene, the very low density lipoprotein receptor (VLDL-R) gene, was reported by Okuizumi et al. to be independently associated with AD in a Japanese population, but not interactive with the APOE4 conferred risk. Their clinic-based data set demonstrated a 2-fold increased risk conferred by the 5-repeat allele of a polymorphism in VLDL-R. As recruitment from a clinic rather than a population-based sample may result in a distortion of allele frequencies, as has been shown with APOE allele frequencies, it is important to investigate this association in a population-based study. We have genotyped both population and clinic-based AD data sets at this VLDL-R polymorphism, and we find no independent association between the VLDL-R gene and the occur rence of AD in either sample. Further, despite the biochemical relationship between the VLDL-R and APOE proteins, we find no significant statistical interaction between the alleles at these loci.

KW - Alzheimer's disease risk

KW - Genetic interaction

KW - Very low density lipoprotein receptor gene

UR - http://www.scopus.com/inward/record.url?scp=0030976712&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0030976712&partnerID=8YFLogxK

U2 - 10.1002/(SICI)1098-2272(1997)14:3<299::AID-GEPI7>3.0.CO;2-0

DO - 10.1002/(SICI)1098-2272(1997)14:3<299::AID-GEPI7>3.0.CO;2-0

M3 - Article

C2 - 9181358

AN - SCOPUS:0030976712

VL - 14

SP - 299

EP - 305

JO - Genetic Epidemiology

JF - Genetic Epidemiology

SN - 0741-0395

IS - 3

ER -